人福医药：咪达唑仑注射液获得德国联邦药品和医疗器械管理局上市许可

Core Viewpoint - Yifan Pharmaceutical announced that its subsidiary, Yichang Renfu Pharmaceutical Co., Ltd., has received marketing authorization for midazolam injection from the German Federal Institute for Drugs and Medical Devices (BfArM) [2] Group 1 - The approval signifies a significant milestone for Yifan Pharmaceutical in expanding its product offerings in the European market [2] - Midazolam is a medication used for sedation, anxiolysis, and amnesia, indicating potential demand in various medical settings [2] - This development may enhance the company's revenue streams and market presence in the pharmaceutical industry [2]